Starting on:
Oct 22, 2026
Ending on:
Dec 31, 2028
Moderator(s):
URL:
Go to activity
Max Credits:
2 Points
Provider:
Daktari Online
Claim Points
Oct 22, 2026
Ending on:
Dec 31, 2028
Moderator(s):
Go to activity
Max Credits:
2 Points
Provider:
Daktari Online
Claim Points
Prostate Specific Antigen: Time for a Closer Look
Starting on:
Oct 22, 2026
Oct 22, 2026
Ending on:
Dec 31, 2028
Dec 31, 2028
Venue:
Description
This CME activity provides healthcare professionals with an overview of prostate-specific antigen (PSA) testing and its role in prostate cancer screening, diagnosis, and monitoring. It explores PSA interpretation, factors influencing PSA levels, the benefits and limitations of PSA testing, and current evidence-based recommendations to support informed clinical decision-making and appropriate patient management.
Objectives
Main Objectives:
1. Explain the role of prostate-specific antigen (PSA) in prostate health assessment and the early detection of prostate cancer.
2. Identify factors that influence PSA levels, including age, benign prostatic hyperplasia, prostatitis, and prostate cancer.
3. Interpret PSA test results and discuss the appropriate use of additional diagnostic investigations in patients with elevated PSA levels.
4. Discuss the benefits, limitations, and potential risks of PSA screening to support shared decision-making and evidence-based patient management.